Endo Optiks, Inc. recently announced the appointment of a Medical Advisory Board of renowned Glaucoma Specialists to support the company in developing clinical and scientific strategy. The Board is chaired by Dr. Brian Francis.

"We are honored and excited to have these distinguished Glaucoma Specialists on our Medical Advisory Board," said Steve Kohn, CEO and co-founder of Endo Optiks. "I am confident that their experience and guidance will be important as we grow within the field of Glaucoma Surgery. Assembling a Medical Advisory Board of this caliber is a key strategy in the ongoing development of Glaucoma Surgery.”

Meet the Board

Ronald Fellman, M.D., OCS
Brian Francis, M.D.
Rob Noecker, M.D.
Nathan Radcliffe, M.D.
Steven R. Sarkisian, Jr., M.D.

Ronald Fellman, M.D., OCS
Dallas, TX 75231-5185

Ronald Fellman is Attending Surgeon and Clinician at Glaucoma Associates of Texas in Dallas and Associate Clinical Professor Emeritus, Dept of Ophthalmology, University of Texas Southwestern Medical Center, Dallas (UTSWMC). Dr Fellman graduated from Tulane Medical School and completed his internship and ophthalmology residency at UTSWMC Dallas and fellowship in glaucoma at Wills Eye Hospital.

He is the recipient of the first American Glaucoma Society (AGS) President’s Award, Secretariat and Senior Honor Awards from the AAO and is past Chair of the Patient Care committee of the AGS and prior AGS councilor to the AAO. He has co-authored over 40 published papers and 15 book chapters on the medical and surgical management of glaucoma and helped create the Medicare Glaucoma Detection Benefit.

Dr Fellman serves on the board of Cure Glaucoma, a foundation dedicated to reduce blindness from glaucoma on a global level.

Brian Francis, M.D.
Doheny Eye Institute
Los Angeles, CA 90033-4500

Dr. Francis is an Associate Professor of Ophthalmology and the holder of the Ralph and Angelyn Riffenburgh Professorship in Glaucoma at the Doheny Eye Institute, Keck School of Medicine, University of Southern California. He completed undergraduate work at Stanford University, and earned his M.D. from the Tulane University School of Medicine in New Orleans. He completed his residency at the Tulane University Department of Ophthalmology. Dr. Francis then completed a glaucoma fellowship at the University of California, San Francisco. He also has a Masters degree from USC in Clinical and Biomedical Investigations.

He is an examiner for the American Board of Ophthalmology, and has been honored by the American Academy of Ophthalmology with an Achievement Award and Secretariat Award. He also serves on the Ophthalmic Technology Assessment Committee of the AAO, evaluating newer technologies in glaucoma. He is on the editorial board and a section editor of Eyenet Magazine, and the glaucoma section editor for Ophthalmology Web. He has over 40 publications in peer reviewed journals, and has authored several book chapters.

He is involved in research concerning neural network analysis of visual fields and virtual reality visual field techniques. He is also working on the development of implantable micro-machines (nano-technology) to diagnose and treat glaucoma. His other interests include novel glaucoma surgical techniques such as the Trabectome, drainage tube implants and endoscopic ciliary body ablation. He is one of the founders of the Ocular Burn Rehabilitation Center which is a collaborative effort of the glaucoma, oculoplastics and cornea services. He is also involved in clinical trials of glaucoma diagnostic technologies, medications and surgical procedures, and has published on the epidemiology of glaucoma and related risk factors.

Rob Noecker, M.D.
UPMC Eye Center
Pittsburgh, PA

Robert J. Noecker, MD, MBA is currently in private practice in Fairfield, CT with Ophthalmic Consultants of Connecticut. He has published on teaches and performs novel glaucoma surgical techniques. He specializes in complex pediatric and adult glaucoma cases especially in combination with cataract surgery. He also specializes in complicated lens implant repositioning and replacement techniques.

Dr. Noecker has over 15 years of experience in developing innovations in imaging, and medical, laser and surgical therapies for glaucoma; Dr. Noecker has conducted over 50 trials on the pharmacologic and surgical treatment of glaucoma, macular degeneration and dry eyes. Dr. Noecker has also helped to innovate and apply novel new materials and surgical techniques to the treatment of glaucoma. He is on the editorial board of many peer-reviewed journals in ophthalmology, has published over 100 peer-reviewed papers and has lectured around in over 30 countries.

Prior to joining OCC, Dr. Noecker was the Vice Chair of UPMC Eye Center, Director of the Glaucoma Service, and Professor of Ophthalmology at the University of Pittsburgh School of Medicine. He was associate director of the electronic health record at UPMC, director of telemedicine for ophthalmology and director of glaucoma teleretina program for Ophthalmology at the Pittsburgh VA. Prior to Pittsburgh, he was on the faculty at Tufts University and was Director of Glaucoma and the Ophthalmology residency program at the University of Arizona School of Medicine. He currently teaches glaucoma diagnosis and treatment regularly at Yale University School of Medicine.

Dr. Noecker did his undergraduate work at MIT, medical school at the University of North Carolina in Chapel Hill, residency in Ophthalmology at the University of Arizona and Fellowship in glaucoma at Tufts University in Boston. He received his M.B.A. from the Eller School of Management at the University of Arizona.

Nathan Radcliffe, M.D.
Director, Glaucoma Service and
Clinical Assistant Professor,
NYU Langone Ophthalmology Associates
Cataract and Glaucoma Surgeon,
New York Eye Surgery Center

Nathan Radcliffe, M.D. is a board certified ophthalmologist who is an experienced glaucoma and cataract surgeon. Prior to June of 2014, Dr. Radcliffe served as the Director of the Glaucoma Service at Weill Cornell Medical College for six years. During his time in academics, Dr. Radcliffe managed the most challenging cataract and glaucoma cases referred from all over the world, published over 40 peer reviewed publications in glaucoma research, gave hundreds lectures on glaucoma and cataract to thousands of ophthalmologists in 40 states and over a dozen different countries, and won awards for his surgical videos and teaching.

Dr. Radcliffe serves on the Skills Transfers Advisory Committee for the American Academy of Ophthalmology, is the Chair of the Multimedia Committee for the American Glaucoma Society and serves on the Glaucoma Clinical Committee for the Association of Cataract and Refractive Surgery. Dr. Radcliffe graduated Alpha Omega Alpha from Temple University School of Medicine and then was transitional resident of the year at the University of Hawaii in Honolulu. He was chief resident at New York University for his ophthalmology residency and was chief glaucoma fellow at the New York Eye and Ear Infirmary.

Steven R. Sarkisian, Jr., M.D.
(Clinical Assoc. Prof.of Ophthal)
University of Oklahoma
College of Medicine
Glaucoma Fellowship Director
Dean McGee Eye Institute

Steven R. Sarkisian, Jr., MD is the director of the glaucoma fellowship at the Dean A. McGee Eye Institute and serves as a clinical associate professor of Ophthalmology at the University of Oklahoma in Oklahoma City. A native of Pennsylvania, Dr. Sarkisian received his undergraduate degree from Wheaton College, in Illinois where he graduated with honors. Following college, Dr. Sarkisian did graduate work at Westminster Theological Seminary in Philadelphia. Remaining in Philadelphia, he received his M.D. degree from Jefferson Medical College followed by an internship at Chestnut Hill Hospital. Dr. Sarkisian completed an ophthalmology residency at the State University of New York Health Science Center (SUNY Downstate) in Brooklyn, New York and did a fellowship in glaucoma at the Hamilton Eye Institute at the University of Tennessee Health Science Center in Memphis, following which he was asked to stay on the faculty where he served until July 2006. Dr. Sarkisian joined the faculty at the Dean A. McGee Eye Institute in August 2006.

Dr Sarkisian has an active interest in surgical innovation for the treatment of glaucoma with involvement in numerous clinical trials. He is the Primary Investigator for the Ologen vs. Mitomycin-C study, a multicenter, prospective randomized trial comparing these two methods of wound modulation in glaucoma filtration surgery as well as numerous other studies currently underway investigating devices in multiple stages of the FDA approval process for the surgical treatment of glaucoma. He has served as Primary Investigator on the Ex-Press vs. trabeculectomy trial (XVT Study), the Ahmed-Baerveldt Comparison Trial (ABC Study) and for the pilot studies which have taken place for the EagleVision glaucoma drainage implants. He has been a co-investigator on the Trabeculectomy vs. Tube Study (TVT Study), the Primary Trabeculectomy vs. Tube Study (PTVT), and the Anecortave Acetate study. Due to his involvement in the development of new glaucoma technology, he has been active in presenting and publishing his work both in America and internationally. He also was nominated by the American Glaucoma Society to be a consultant to the FDA Ophthalmic Device Panel, where he has served since 2009.

Dr. Sarkisian currently serves on the Editorial Board of /Glaucoma Today/ and is an editorial reviewer for numerous ophthalmology journals. His professional service also includes membership on the glaucoma program committee for both the American Society of Cataract and Refractive Surgery (ASCRS) and the American Academy of Ophthalmology (AAO). He has served as a moderator and speaker at the annual meetings of the ASCRS and the AAO as well as the ASCRS Winter Update Meeting. His responsibilities also include reviewing all wet labs/skills courses, as well as abstracts for poster/paper presentations related to glaucoma for both the ASCRS and AAO. He also is the Program Chairman for the University of Oklahoma Department of Ophthalmology Annual Ophthalmology Symposium.

Dr. Sarkisian is listed in Woodward/White’s The Best Doctors in America, and among America’s Top Ophthalmologists by the Consumers’ Research Council of America. He is also listed in Cambridge Who’s Who and the Global directory of Who’s Who and has been listed among The Best Doctors in Oklahoma by Oklahoma Magazine.

Dr. Sarkisian has retained an interest in biomedical ethics, having served on the Professional Code of Conduct Committee at Jefferson Medical College, the Ethics Committee of Chestnut Hill Hospital, and the UT Faculty Senate. He also has been active in organized medicine, having served as President of the Jefferson Chapter of the AMA. He also served as a Trustee of the Pennsylvania Medical Society as a medical student.

Certified by the American Board of Ophthalmology, Dr. Sarkisian is also a member of the American Glaucoma Society, the Chandler-Grant Glaucoma Society, the American Academy of Ophthalmology, the American Medical Association, the Association for Research in Vision and Ophthalmology, the American Society of Cataract and Refractive Surgery, and numerous local and state ophthalmology societies.

He and his wife Anne have four children and reside in Edmond, Oklahoma.